Evaluating the early impacts of delisting high-strength opioids on patterns of prescribing in Ontario.

CONCLUSION: Delisting high-strength opioids substantially reduced the number of highstrength opioid recipients and reduced the overall volume of long-acting opioids dispensed in Ontario through the public drug program. Future studies should examine its impact on patient outcomes. PMID: 29911823 [PubMed - in process]

https://www.ncbi.nlm.nih.gov/pubmed/29911823?dopt=Abstract

Source: Health Promotion and Chronic Disease Prevention in Canada - June 19, 2018 Category: International Medicine & Public Health Tags: Health Promot Chronic Dis Prev Can Source Type: research